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ABSTRACT 
Objective: To develop an accurate, precise and linear RP-HPLC method for simultaneous quantitative estimation of Metformin hydrochloride and 
Nateglinide in tablets and validate as per ICH guidelines. 
Methods: The method used a reverse phase column, Inertsil C18-ODS 3V (250×4.6 mm, 5 µm), a mobile phase comprising of phosphate buffer (p
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4.0): Acetonitrile: methanol (30:60:10) flow rate of 1.0 ml/min and a detection wavelength of 221 nm using a UV detector. 
Results: The developed method resulted in elution of Metformin hydrochloride at 2.45 min and Nateglinide at 4.21 min. The calibration curves 
were linear (r²=0.999) in the concentration range of 60-140 µg/ml and 14.4-33.2 µg/ml for Metformin hydrochloride and Nateglinide respectively. 
The percentage recoveries were found to be 99.59-101.36 for Metformin hydrochloride and 98.43-101.38 for Nateglinide. The LOD was found to be 
2.18 µg/ml and 1.55 µg/ml for Metformin hydrochloride and Nateglinide respectively. LOQ was found to be 8.52µg/ml and 4.69µg/ml for Metformin 
hydrochloride and Nateglinide respectively.  
Conclusion: A simple, accurate, precise, linear and rapid RP-HPLC method was developed for simultaneous quantitative estimation of Metformin 
hydrochloride and Nateglinide in bulk and pharmaceutical formulation and validated as per ICH guidelines. Hence, the method holds good for the 
routine analysis of Metformin hydrochloride and Nateglinide in various pharmaceutical industries as well as in academics. 
© 2016 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/) 
 
INTRODUCTION 
Metformin hydrochloride (fig. 1) is 1, 1-Dimethyl biguanide 
monohydrochloride. It is the first-line medication for the treatment 
of type 2 diabetes. It is a biguanide antihyperglycemic agent used for 
treating noninsulin dependent diabetes mellitus (NIDDM). It 
improves glycemic control by decreasing hepatic glucose 
production, decreasing glucose absorption and increasing insulin-
mediated glucose uptake. Metformin is the only oral anti-








Fig. 1: Structure of metformin hydrochloride 
 
Nateglinide (fig. 2) is 2-(4-isoopropylcyclohexanecarboxamido)-3-
phenylpropanoic acid. It is an oral antihyperglycemic agent used for the 
treatment of NIDDM. It belongs to the Meglitinide class of short-acting 
insulin secretagogues. It lowers blood glucose by stimulating the release 
of insulin from the pancreas, by closing ATP-dependent potassium 
channels in the membrane of the β cells. This depolarizes the β cells and 
causes voltage-gated calcium channels to open. The resulting calcium 
influx induces fusion of insulin-containing vesicles with the cell 
membrane and insulin 
A detailed literature survey revealed that there was a 
spectrophotometric method for simultaneous estimation of 
Metformin with other combination [1] and Nateglinide in tablet 
dosage form [2], and HPTLC method [3] have been established for 
simultaneous analysis of Metformin hydrochloride and Repaglinide. 
There were various RP-HPLC methods have been developed for the 
determination Metformin hydrochloride in combination with other 
drugs [4-11]. However, there was no RP-HPLC Method has been 
reported for simultaneous estimation of Metformin hydrochloride 
and Nateglinide, we presented easy, rapid, accurate and specific 
HPLC method for simultaneous estimation of RP-HPLC assay 
procedure for the analysis of Metformin hydrochloride and 
Nateglinide in bulk and tablet dosage form. The developed method 
was validated as per ICH guidelines [12]. 
 
secretion occurs. Nateglinide is extensively 






Fig. 2: Structure of nateglinide 
 
MATERIALS AND METHODS 
Pharmaceutical grade Metformin hydrochloride and Nateglinide 
were supplied as a gift sample by Chandra labs, Hyderabad and 
marketed formulation (NETOP PLUS, Metformin-500 mg, and 
Nateglinide-120 mg) was purchased from the local market. 
Methanol, Orthophosphoric acid (OPA), Acetonitrile and HPLC grade 
water were obtained from Merck. All solvents used in this work are 
HPLC grade. RP-HPLC Shimadzu (LC 20ATVP) model with Spin 
chrome (LC SOLUTIONS) software was employed in this method. 
Analytical column used for the separation of analytes is Inertsil ODS 
C18 (250x4.6 mm, 5μ).  
International Journal of Pharmacy and Pharmaceutical Sciences 
ISSN- 0975-1491                 Vol 8, Issue 4, 2016 
Chengalva et al. 
Int J Pharm Pharm Sci, Vol 8, Issue 4, 267-271 
268 
Methods  
Selection of wavelength  
Standard solutions of Metformin hydrochloride and Nateglinide 
were prepared at the concentration of 10 μg/ml scanned by UV/Vis 
spectrophotometer at the range of 200-400 nm. UV spectrums of 
Metformin hydrochloride (fig. 3) and Nateglinide (fig. 4) were 
shown below. The isosbestic point selected for simultaneous 
estimation was 221 nm (fig. 5). 
 
 
Fig. 3: UV spectrum of Nateglinide 
 
 
Fig. 4: UV spectrum of metformin hydrochloride 
 
 
Fig. 5: UV overlaps spectrum of Nateglinide and Metformin 
hydrochloride 
 
Chromatographic conditions  
The developed method used a reverse phase C18 column, Waters 
Inertsil ODS 3V (250x4.6 mm, 5μ), a mobile phase of phosphate 
buffer (pH 4.0): Acetonitrile: methanol (30:60:10), flow rate of 1.0 
ml/min and a detection wavelength of 221 nm using a UV detector. 
Preparation of phosphate buffer 
Accurately 2.7 g of potassium dihydrogen phosphate (KH2PO4) was 
weighed and dissolved in water and volume was made up to 1000 
ml with water. The PH was adjusted to 4.0 by using Orthophosphoric 
acid. The buffer was filtered to remove all fine undissolved particles.  
Preparation of mobile phase  
A mixture of 30 volumes of phosphate Buffer, 60 volumes of 
Acetonitrile and 10 volumes of methanol was prepared. The mobile 
phase was sonicated for 10 min to remove gasses. 
Diluent 
The mobile phase was used as diluent. 
Preparation of standard solutions 
Standard stock solutions of Metformin hydrochloride and 
Nateglinide were prepared by dissolving 100 mg of Metformin and 
24 mg of Nateglinide insufficient mobile phase. After that, the 
solution was filtered and sonicated for 5 min and diluted to 100 ml 
with mobile phase. Further dilutions were prepared in 5 replicates 
of 100 μg/ml of Metformin and 24 μg/ml of Nateglinide, which was 
made by adding 1 ml of stock solution to 10 ml of mobile phase. This 
has been treated as 100 % target concentration. 
Preparation of sample solution 
20 tablets each containing 500 mg of Metformin hydrochloride and 
120 mg of Nateglinide were weighed and taken into a mortar and 
crushed to fine powder and uniformly mixed. Primary stock 
solutions of Metformin hydrochloride and Nateglinide (μg/ml) were 
prepared by dissolving a weight equivalent to 500 mg of Metformin 
hydrochloride and 120 mg of Nateglinide and dissolved in sufficient 
mobile phase. After that, the solution was filtered by syringe filter 
and sonicated for 5 min and dilute to 100 ml with mobile phase. 
Further dilutions were prepared in 5 replicates of 100 μg/ml of 
Metformin hydrochloride, and 24 μg/ml of Nateglinide was made by 
adding 1 ml of stock solution to 10 ml of mobile phase. That has 
been treated as 100 % target concentration. 
RESULTS AND DISCUSSION 
Method development 
Different chromatographic conditions were tried for better 
separation and resolution. Inertsil C18-ODS 3V (250×4.6 mm, 5 µm) 
column was found satisfactory. Peak purity of Metformin 
hydrochloride and Nateglinide was checked using UV detector and 
221 nm was considered satisfactory for detecting both the drugs 
with adequate sensitivity. A number of solvents in the different ratio 
over a wide range of pH were tried, but either peak shape was broad 
or resolution was not good. Repeated trials to obtain good, sharp 
peak with an efficient resolution between two peaks of Metformin 
hydrochloride and Nateglinide done on a C18 column in isocratic 
HPLC gave satisfactory results. The run time was good in isocratic 
trial with mobile phase consisting of phosphate buffer (pH 4.0): 
Acetonitrile: methanol (30:60:10) and C18-ODS 3V (250×4.6 mm, 5 
µm) column, flow rate 1.0 ml/min and detection wavelength 221 nm 
gave the satisfactory results in terms of retention time, resolution, 
symmetry and sensitivity. A typical RP-HPLC chromatogram for 
simultaneous determination of Metformin hydrochloride and 
Nateglinide from standard preparation and from pharmaceutical 
formulation was shown in (fig. 6 and 7). 
 
 
Fig. 6: Typical chromatogram of standard solution 
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Fig. 7: Typical chromatogram of sample solution 
 
Method validation 
The developed RP-HPLC method was validated for parameters like 
system suitability, linearity, accuracy, precision, limit of detection 
(LOD), limit of quantitation (LOQ) and robustness according to ICH 
guidelines. 
System suitability 
Standard solutions were prepared as per the test method and 
injected into the chromatographic system. The system suitability 
parameters like theoretical plates, resolution and asymmetric factor 
were evaluated. The system suitability parameters were tabulated in 
table 1. All the parameters were found to be within the limits. 
Precision 
Method precision 
The precision of the method was verified by precision method 
studies. The sample solution was prepared at working concentration 
and analysis was carried out at replicating. The sample solutions of 
Metformin hydrochloride and Nateglinide were prepared as per the 
test method and injected 6 times into the column. The results of 
precision were tabulated in table 2. The average was taken, and % 
RSD was calculated and reported. % RSD values were within the 
limits, and the method was found to be precise. 
Linearity 
The linearity of the test solutions for the assay method was prepared 
from Metformin hydrochloride and Nateglinide standard stock 
solution at five concentration levels from 50% to 150% of assay 
concentration. The peak area versus concentration data was treated 
by least-squares linear regression analysis (fig. 8 and 9). The results 
have shown an excellent correlation between peak areas and 
concentration within the concentration range of 60–140 μg/ml for 
Metformin hydrochloride, 14.4–33.2 μg/ml for Nateglinide (tables 3-
4). The correlation coefficients were found to be 0.999 for both the 
drugs, which meet the method validation acceptance criteria and 
hence the method was said to be linear for both the drugs. 
 
Table 1: Results of system suitability studies 
Parameters  Acceptance limits Metformin hydrochloride Nateglinide  
Retention time (min) - 2.453 4.217 
Resolution NLT 2 - 14.232 
Theoretical plates NLT 2000 8489 7583 
Tailing factor NMT 2 1.706 1.556 
# min: minutes 
 
Table 2: Method precision data 
n Metformin hydrochloride Nateglinide 
 Rt Peak area Rt Peak area 
Injection 1 2.459 3984.852 4.253 399.316 
Injection 2 2.456 3983.028 4.243 396.285 
Injection 3 2.453 3986.756 4.227 380.420 
Injection 4 2.457 3983.864 4.210 390.391 
Injection 5 2.459 3955.954 4.300 385.999 
Injection 6 2.460 3915.924 4.367 385.427 
Average 2.456 3968.396 4.267 389.640 
SD 0.004 28.176 0.058 7.132 
% RSD 0.164 0.710 1.35 1.83 
# Rt: Retention times, # n: number of injections=6 
 
 
Fig. 8: Linearity chart for Metformin hydrochloride 
 
Accuracy 
The accuracy of the method was determined by recovery studies by 
the determination of % mean recovery of both the drugs at three 
different levels (80 %, 100 % and 120%). At each level, three 
determinations were performed. The percentage recovery and mean 
percentage recovery were calculated for the drug was shown in table 
4. The observed data were within the required range, which indicates 




Fig. 9: Linearity chart for Nateglinide
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Table 3: Linearity data for Metformin hydrochloride and Nateglinide 








50 60 2088.713 14.4 201.895 
75 80 3002.121 19.2 292.713 
100 100 3941.042 24 385.139 
125 120 4890.891 28.8 476.353 
150 140 5854.513 33.2 560.788 
Correlation 
Coefficient  
0.9998  0.9996  
Slope 37.68  3.60  
  
Table 4: Results of accuracy 
Level (%) Metformin hydrochloride  Nateglinide  
 % Recovery % Mean % Recovery % Mean 
80 98.59 99.59 100.74 100.42 
80 99.63 99.90 
80 100.57 100.63 
100 99.48 100.46 99.53 99.30 
100 100.54 98.43 
100 101.36 99.95 
150 101.20 100.09 101.38 101.14 
 150 99.08 100.78 
150 100.01 101.27 
 
Table 5: Results of robustness 
Parameter Metformin hydrochloride Nateglinide 
 Plate count Tailing Plate count Tailing 
Less flow rate (0.8 ml/min) 8828 1.765 7336 1.500 
More flow rate (1.2 ml/min) 8789 1.706 7114 1.556 
Less wavelength 216 nm 8828 1.765 7180 1.519 
More wavelength 226 nm 8451 1.667 7123 1.538 
 
Table 6: LOD and LOQ 
Sample name LOD(μg/ml) LOQ(μg/ml) 
Metformin hydrochloride 2.18 8.52 
Nateglinide 1.55 4.69 
 
Robustness 
To determine the robustness of the developed method, experimental 
conditions were deliberately altered, and the system suitability 
parameters were evaluated. The solutions prepared as per the test 
method and injected at different variable conditions like flow rate 
(0.8, 1.2 ml/min.) and wavelength (219 nm, 223 nm), system 
suitability parameters were compared with that of method 
precision. The results were tabulated in table 5. At the flow rate of 
1.0 ml/min shows, a sharp peak with good resolution and rest of the 
flow rates were found to be not satisfactory. The method passed all 
system suitability parameters indicating that the method was 
robust. 
Detection limit and quantification limit 
Limit of detection (LOD) which represents the concentration of the 
analyte at S/N ratio of 3 and limit of Quantification (LOQ) at which 
S/N was 10 were determined experimentally for the proposed 
methods and results were given in table 6. Hence, the detection 
limits and quantitation limits of the drugs were given S/N ratios of 3 
and 10 respectively. 
CONCLUSION 
The proposed RP-HPLC method was found to be simple, specific, 
accurate, precise, robust, rapid and economical. This method gives 
good resolution between all the two compounds with a short 
analysis time. The proposed RP-HPLC method can be useful for 
routine analysis of Metformin hydrochloride and Nateglinide in the 
tablet dosage form.  
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